NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,000 | -67.7% | 138 | -64.4% | 0.00% | -62.5% |
| Q3 2016 | $31,000 | -3.1% | 388 | 0.0% | 0.01% | -11.1% |
| Q2 2016 | $32,000 | +14.3% | 388 | 0.0% | 0.01% | +28.6% |
| Q1 2016 | $28,000 | -17.6% | 388 | 0.0% | 0.01% | -22.2% |
| Q4 2015 | $34,000 | -5.6% | 388 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $36,000 | -7.7% | 388 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $39,000 | -32.8% | 388 | -33.4% | 0.01% | -29.4% |
| Q1 2015 | $58,000 | +7.4% | 583 | 0.0% | 0.02% | -5.6% |
| Q4 2014 | $54,000 | -1.8% | 583 | 0.0% | 0.02% | 0.0% |
| Q3 2014 | $55,000 | +3.8% | 583 | 0.0% | 0.02% | +5.9% |
| Q2 2014 | $53,000 | +6.0% | 583 | 0.0% | 0.02% | +6.2% |
| Q1 2014 | $50,000 | -42.5% | 583 | -46.2% | 0.02% | -44.8% |
| Q4 2013 | $87,000 | +4.8% | 1,083 | 0.0% | 0.03% | 0.0% |
| Q3 2013 | $83,000 | +12.2% | 1,083 | +3.1% | 0.03% | +16.0% |
| Q2 2013 | $74,000 | – | 1,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |